StockData
CCELNYSEServices-Misc Health & Allied Services, NECFiscal year ends November 30

CRYO CELL INTERNATIONAL INC

Financials through Q3 FY2026, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 9, 2026
$4.65+0.23 (+5.20%)

Close on Oct 19, 2026

Market cap
$37.50M
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q3 FY2024
Ended Aug 31, 2024
Oct 17, 2024After market close$8.07M$0.13–
Q4 FY2021
Ended Nov 30, 2021
Feb 24, 2022After market close–––
Q3 FY2021
Ended Aug 31, 2021
Oct 15, 2021After market close–––
Q2 FY2021
Ended May 31, 2021
Jul 19, 2021After market close–––
Q1 FY2021
Ended Feb 28, 2021
Apr 16, 2021After market close–––
Q4 FY2020
Ended Nov 30, 2020
Feb 25, 2021After market close–––
Q3 FY2020
Ended Aug 31, 2020
Oct 19, 2020After market close–––
Q2 FY2020
Ended May 31, 2020
Jul 13, 2020After market close–––
Q1 FY2020
Ended Feb 29, 2020
Mar 2, 2020After market close–––
Q3 FY2019
Ended Aug 31, 2019
Oct 17, 2019After market close–––
Q2 FY2019
Ended May 31, 2019
Jul 25, 2019After market close–––
Q1 FY2019
Ended Feb 28, 2019
Mar 1, 2019After market close–––

Press releases

Announcements Cryo Cell International filed with the SEC